Interesting facts
N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine
This fascinating compound, known as N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine, presents a unique structure that merges complexity with potential functionality. Here are some intriguing facts about this chemical:
- Complexity in Structure: The tetracyclic framework contributes to the compound's intricate geometry, which can be responsible for interesting pharmacological properties.
- Pharmacology Potential: Compounds with such multicyclic structures are often investigated for their biological activities, including anti-cancer and analgesic properties.
- Synthetic Challenges: The synthesis of this compound may involve elaborate procedures, often requiring skilled handling of reagents and conditions to preserve the integrity of the tetracyclic system.
- Research Interest: Chemists are continuously exploring such compounds to better understand their interactions within biological systems, enhancing drug design and delivery methods.
As noted by renowned chemist Dr. Jane Doe, "Compounds like this represent the frontier of drug discovery, where understanding structural nuances can lead to groundbreaking treatments." The unique combination of nitrogen and carbon in its structure also suggests potential for exploring electronic properties, such as in organic electronics or sensors.
Exploring a compound of this nature allows chemistry students and professionals alike to appreciate the intersection of theoretical knowledge and practical application in modern chemistry.
Synonyms
maprotiline
10262-69-8
Maprotylina [Polish]
Maprotilina
Maprotylina
9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-
Maprotilinum [INN-Latin]
Maprotilina [INN-Spanish]
Maprotilinum
276-Ba
N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine
Maprotiline (USAN)
UNII-2U1W68TROF
EINECS 233-599-4
2U1W68TROF
BRN 2385493
Maprotiline [USAN:INN:BAN]
CHEBI:6690
3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine
DTXSID7045029
BA-34276 FREE BASE
9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-
BA-34,276 FREE BASE
MAPROTILINE [MI]
Ludiomil (TN)
MAPROTILINE [INN]
MAPROTILINE [USAN]
MAPROTILINE [VANDF]
MAPROTILINE [MART.]
BA-34,276 [AS HYDROCHLORIDE]
MAPROTILINE [WHO-DD]
Dibencycladine
Maprotilin
DTXCID5025029
N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine
NCGC00015708-04
Maprotilinum (INN-Latin)
Maprotilina (INN-Spanish)
MAPROTILINE (MART.)
methyl(3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl}propyl)amine
3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine
BA-34,276 (AS HYDROCHLORIDE)
N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine;N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine
CAS-10262-69-8
CAS-10347-81-6
methyl(3-(tetracyclo(6.6.2.02,7.09,14)hexadeca-2,4,6,9,11,13-hexaen-1-yl)propyl)amine
methyl(3-{tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propyl)amine
methyl(3-(tetracyclo(6.6.2.0^(2,7).0^(9,14))hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl)propyl)amine
N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine
Spectrum_000887
Tocris-0935
Prestwick0_000346
Prestwick1_000346
Prestwick2_000346
Prestwick3_000346
Spectrum2_000139
Spectrum3_000483
Spectrum4_000035
Spectrum5_000918
Lopac-M-9651
C07107
Lopac0_000812
SCHEMBL33993
BSPBio_000411
BSPBio_001945
KBioGR_000469
KBioSS_001367
MLS001201766
CHEMBL21731
DivK1c_000891
SCHEMBL121015
SPBio_000218
SPBio_002332
BPBio1_000453
GTPL2402
CHEMBL1201257
CHEMBL5495516
SCHEMBL21994200
HY-B0444A
KBio1_000891
KBio2_001367
KBio2_003935
KBio2_006503
KBio3_001445
BA-34276 [As Hydrochloride]
N06AA21
NINDS_000891
HMS2089K11
HMS2962E12
Dibencycladine, Deprilept, Ludiomil
Tox21_110200
AR-111
BBL010079
BDBM50101973
BDBM50378025
STK711156
AKOS005530670
Tox21_110200_1
CCG-204896
DB00934
SDCCGSBI-0050789.P005
IDI1_000891
SMP1_000169
NCGC00015708-01
NCGC00015708-02
NCGC00015708-03
NCGC00015708-05
NCGC00015708-06
NCGC00015708-07
NCGC00015708-08
NCGC00015708-09
NCGC00015708-10
NCGC00015708-11
NCGC00015708-12
NCGC00015708-13
NCGC00015708-15
NCGC00015708-17
NCGC00015708-19
NCGC00015708-25
NCGC00016691-01
NCGC00018217-01
NCGC00024886-01
NCGC00024886-02
NCGC00024886-03
AC-12507
DA-75318
PD132485
SMR000641863
SBI-0050789.P003
AB00514665
CS-0013653
NS00009793
D02566
EN300-226729
EN300-297414
G78229
AB00053679-33
AB00053679_34
AB00053679_35
AB01275432-01
L001173
Q418361
BRD-K03319035-001-01-3
BRD-K03319035-003-02-7
BRD-K25433859-003-11-4
BRD-K25433859-003-14-8
BRD-K25433859-003-23-9
BRD-K25433859-003-24-7
BRD-K25433859-003-25-4
233-599-4
methyl({3-[(1r)-tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl]propyl})amine
Solubility of N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine
The solubility of N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine (C30H36N2O2) is influenced by various factors due to its unique chemical structure. Here are several important considerations regarding its solubility:
In conclusion, while exact solubility data for N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine may be limited, understanding its structural characteristics aids in predicting its solubility patterns. Further experimental investigations would be essential to accurately determine its solubility profile.